Funds and ETFs Shandong Xinhua Pharmaceutical Company Limited Shenzhen S.E.

Equities

000756

CNE000000BG1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
16 CNY +1.91% Intraday chart for Shandong Xinhua Pharmaceutical Company Limited +4.17% -21.49%

ETFs positioned on Shandong Xinhua Pharmaceutical Company Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 117 M€ +1.54% -
0.00% 34 M€ +2.43% -
0.00% 7 M€ +0.11% -
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.
More about the company
  1. Stock Market
  2. Equities
  3. 719 Stock
  4. 000756 Stock
  5. Funds and ETFs Shandong Xinhua Pharmaceutical Company Limited